Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 60 2013 062 409.7 |
| 96 | EP file number | EAKZ | 17 17 2927.0 |
| 97 | EP publication number | EPN | 3243826 |
| 54 | Designation/title | TI | IMIDAZOTHIADIAZOL- UND IMIDAZOPYRAZINDERIVATE ALS PROTEASEAKTIVIERTE REZEPTOR 4 (PAR4)-INHIBITOREN ZUR BEHANDLUNG VON THROMBOZYTENAGGREGATION |
| 51 | IPC main class | ICM
(ICMV) | C07D 519/00 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/433 (2006.01), C07D 513/04 (2006.01), A61K 31/5025 (2006.01), C07D 487/04 (2006.01), A61K 31/4355 (2006.01), A61P 7/02 (2006.01) |
| 22 | DE application date | DAT | Apr 24, 2013 |
| 96 | EP application date | EAT | Apr 24, 2013 |
| 43 | Date of first publication | OT | Nov 15, 2017 |
| Date of publication of grant | PET | Oct 30, 2019 |
| 71/73 | Applicant/owner | INH | Bristol-Myers Squibb Company, Princeton, N.J., US; Université de Montréal, Montreal, Quebec, CA |
| 72 | Inventor | IN | BANVILLE, Jacques, Montréal, Québec H3T 1J4, CA; RÉMILLARD, Roger, Napierville, Québec J0J 1L0, CA; RUEDIGER, Edward H., Montréal, Québec H3T 1J4, CA; DEON, Daniel H., Denver, CO 80230, US; GAGNON, Marc, Montréal, Québec H3T 1J4, CA; DUBÉ, Laurence, Montréal, Québec H3T 1J4, CA; GUY, Julia, Montréal, Québec H3T 1J4, CA; PRIESTLEY, Eldon Scott, Pennington, NJ 08534, US; POSY, Shoshana L., Princeton, NJ 08543, US; MAXWELL, Brad D., Doylestown, PA 18902, US; WONG, Pancras C., Pennington, NJ 08534, US; LAWRENCE, Michael R., Pennington, NJ 08534, US; MILLER, Michael M., Princeton, NJ 08543, US |
| Address for service | | Marks & Clerk (Luxembourg) LLP, 1017 LUXEMBOURG, LU |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
201361787680 P
Mar 15, 2013
|
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
201261638577 P
Apr 26, 2012
|
| Due date | FT
FG | Apr 30, 2025
Annual fee for the 13th year
Patent fees |
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003243826A1
Searchable text:
EP000003243826A1
Original document:
EP000003243826B1
Searchable text:
EP000003243826B1 |
| 43 | Date of first publication | EVT | Nov 15, 2017 |
| Date of the first transfer into DPMAregister | EREGT | Nov 16, 2017 |
| Date of the (most recent) update in DPMAregister | REGT | May 8, 2024
(Show all update days)(Hide all update days)- May 8, 2024; Mar 13, 2024; Mar 9, 2023; Mar 10, 2022; Apr 8, 2021; Oct 22, 2020; Sep 17, 2020; Apr 23, 2020; Nov 23, 2019; Nov 21, 2019; Oct 16, 2019; Oct 10, 2019; May 31, 2018
- Historical data not available for this/these date(s)
- Nov 16, 2017
- Date of the first transfer into DPMAregister
|
